October 3, 2018
Researchers at the Abramson Cancer Center tested a new immunotherapy approach utilizing a therapeutic vaccine in two groups of patients with advanced head and neck squamous cell carcinoma (HNSCCa), and found 86 percent showed elevated T cell activity. It is the first study to show that the vaccine can help immune cells infiltrate tumors. HNSCCa […]
